AR079300A1 - Procedimiento de preparacion de un derivado de combretastatina e intermediarios de reaccion - Google Patents
Procedimiento de preparacion de un derivado de combretastatina e intermediarios de reaccionInfo
- Publication number
- AR079300A1 AR079300A1 ARP100104450A ARP100104450A AR079300A1 AR 079300 A1 AR079300 A1 AR 079300A1 AR P100104450 A ARP100104450 A AR P100104450A AR P100104450 A ARP100104450 A AR P100104450A AR 079300 A1 AR079300 A1 AR 079300A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- compound
- group
- phenyl
- derivative
- Prior art date
Links
- 238000006243 chemical reaction Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 3
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 3
- 150000004814 combretastatins Chemical class 0.000 abstract 3
- WFGCDTSPYBABST-UHFFFAOYSA-N (3,4,5-trimethoxyphenyl)methylphosphane Chemical compound COC1=CC(CP)=CC(OC)=C1OC WFGCDTSPYBABST-UHFFFAOYSA-N 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 abstract 2
- 125000003158 alcohol group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 238000010511 deprotection reaction Methods 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000006239 protecting group Chemical group 0.000 abstract 2
- 238000000746 purification Methods 0.000 abstract 2
- 125000001544 thienyl group Chemical group 0.000 abstract 2
- -1 (3,4,5-trimethoxybenzyl) phosphonium halide Chemical class 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- 150000004820 halides Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C233/07—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La invencion se refiere a un procedimiento de preparacion de un derivado de combretastatina (1) o (2): que comprende las etapas siguientes: - se hace reaccionar el halogenuro de triaril(3,4,5-trimetoxibencil)fosfonio (3) en la que Ar significa un grupo de arilo elegido entre fenilo o tienilo, con formula (4) o bien formula (5), con el fin de obtener, respectivamente, el compuesto (6) o bien (7): - luego, en el transcurso de una etapa de desproteccion en presencia de un ácido y/o de una base, el compuesto de formula (6) o (7) conduce, después de una etapa eventual de purificacion, al compuesto de formula (1) o (2). Reivindicacion 1: Procedimiento de preparacion de un derivado de combretastatina de formula (1) o (2): Significando A- el anion asociado a un ácido AH, que comprende las etapas siguientes: - se hace reaccionar, en presencia de una base, el halogenuro de triaril(3,4,5- trimetoxibencil)fosfonio (3) en la que Ar significa un grupo de arilo elegido entre fenilo o tienilo, sustituido eventualmente con un grupo de alquilo (C1-4), alcoxi (C1-4) o halogeno, con: - formula (4) en la que R y R' representan: - o cada uno un grupo de alquilo (C1-4); - o bien R representa un grupo de fenilo sustituido eventualmente con un grupo alcoxi (C1-4) y R' representa un átomo de hidrogeno; - o bien R y R' forman conjuntamente con el átomo de carbono al que están unidos un grupo de cicloalquilo (C3-7); - o bien de formula (5) en la que PG1 representa un grupo protector de la funcion alcohol, representando X Boc, Fmoc o CBZ, con el fin de obtener, respectivamente, el compuesto (6) o bien (7): - luego, en el transcurso de una etapa de desproteccion en presencia de un ácido y/o de una base, el compuesto de formula 6 o 7 conduce, después de una etapa eventual de purificacion, al compuesto de formula (1) o (2). Reivindicacion 7: Compuesto de formula (4): en la que R y R' representan: o cada uno un grupo de alquilo (C1-4); o bien R representa un grupo de fenilo sustituido eventualmente con un grupo alcoxi (C1-4) y R' representa un átomo de hidrogeno; o bien R y R' forman conjuntamente con el átomo de carbono al que están unidos un grupo de cicloalquilo (C3-7); y X representa Boc, Fmoc o CBZ. Reivindicacion 10: Compuesto de formula (5): en la que PG1 representa un grupo protector de la funcion alcohol, y X representa Boc, Fmoc o CBZ.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0905837A FR2953518B1 (fr) | 2009-12-03 | 2009-12-03 | Procede de preparation d'un derive de combretastatine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR079300A1 true AR079300A1 (es) | 2012-01-18 |
Family
ID=42165674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP100104450A AR079300A1 (es) | 2009-12-03 | 2010-12-02 | Procedimiento de preparacion de un derivado de combretastatina e intermediarios de reaccion |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20120302759A1 (es) |
| EP (1) | EP2507218A1 (es) |
| JP (1) | JP2013512883A (es) |
| KR (1) | KR20120104988A (es) |
| CN (1) | CN102906076A (es) |
| AR (1) | AR079300A1 (es) |
| AU (1) | AU2010326423A1 (es) |
| BR (1) | BR112012012908A2 (es) |
| CA (1) | CA2782701A1 (es) |
| FR (1) | FR2953518B1 (es) |
| IL (1) | IL220059A0 (es) |
| MX (1) | MX2012006388A (es) |
| RU (1) | RU2012127575A (es) |
| SG (1) | SG181467A1 (es) |
| TW (1) | TW201127790A (es) |
| UY (1) | UY33080A (es) |
| WO (1) | WO2011067538A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2805705B1 (en) | 2013-05-23 | 2016-11-09 | IP Gesellschaft für Management mbH | Packaging with one or more administration units comprising a sodium salt of (R)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1 H-imidazol-4-yl)-propionic acid |
| CN104817519B (zh) * | 2015-05-11 | 2016-11-16 | 中国药科大学 | 一类ca-4的衍生物、其制法及其医药用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW325458B (en) * | 1993-09-08 | 1998-01-21 | Ajinomoto Kk | Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer |
| TW334418B (en) * | 1995-03-07 | 1998-06-21 | Ajinomoto Kk | Stilbene derivatives and pharmaceutical compositions |
| EP1068870B1 (en) | 1998-04-03 | 2006-06-07 | Ajinomoto Co., Inc. | Antitumor agents |
| GB9903403D0 (en) * | 1999-02-16 | 1999-04-07 | Angiogene Pharm Ltd | Substituted stilbene compounds with vascular damaging activity |
| JP4826051B2 (ja) | 2000-03-17 | 2011-11-30 | 味の素株式会社 | スチルベン誘導体の新規結晶及びその製造方法 |
| WO2002006279A1 (en) | 2000-07-17 | 2002-01-24 | Oxigene Inc | Efficient method of synthesizing combretastatin a-4 prodrugs |
| JP4779298B2 (ja) | 2001-06-25 | 2011-09-28 | 味の素株式会社 | 抗腫瘍剤 |
| US6759555B2 (en) * | 2002-04-11 | 2004-07-06 | Aventis Pharma S.A. | Process for the preparation of combretastatins |
| FR2838437B1 (fr) * | 2002-04-11 | 2004-06-04 | Aventis Pharma Sa | Procedes de preparation de combretastatines |
| WO2006042215A1 (en) | 2004-10-08 | 2006-04-20 | Janssen Pharmaceutica, N.V. | 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives |
| FR2928148B1 (fr) | 2008-02-28 | 2013-01-18 | Sanofi Aventis | Procede de preparation de combretastatine |
-
2009
- 2009-12-03 FR FR0905837A patent/FR2953518B1/fr not_active Expired - Fee Related
-
2010
- 2010-12-02 MX MX2012006388A patent/MX2012006388A/es not_active Application Discontinuation
- 2010-12-02 AR ARP100104450A patent/AR079300A1/es unknown
- 2010-12-02 AU AU2010326423A patent/AU2010326423A1/en not_active Abandoned
- 2010-12-02 SG SG2012040374A patent/SG181467A1/en unknown
- 2010-12-02 CN CN2010800545408A patent/CN102906076A/zh active Pending
- 2010-12-02 CA CA2782701A patent/CA2782701A1/fr not_active Abandoned
- 2010-12-02 JP JP2012541565A patent/JP2013512883A/ja not_active Withdrawn
- 2010-12-02 WO PCT/FR2010/052592 patent/WO2011067538A1/fr not_active Ceased
- 2010-12-02 BR BR112012012908A patent/BR112012012908A2/pt not_active IP Right Cessation
- 2010-12-02 KR KR1020127014273A patent/KR20120104988A/ko not_active Withdrawn
- 2010-12-02 EP EP10801618A patent/EP2507218A1/fr not_active Withdrawn
- 2010-12-02 RU RU2012127575/04A patent/RU2012127575A/ru not_active Application Discontinuation
- 2010-12-02 TW TW099141920A patent/TW201127790A/zh unknown
- 2010-12-03 UY UY33080A patent/UY33080A/es not_active Application Discontinuation
-
2012
- 2012-05-30 IL IL220059A patent/IL220059A0/en unknown
- 2012-06-04 US US13/487,606 patent/US20120302759A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL220059A0 (en) | 2012-09-24 |
| RU2012127575A (ru) | 2014-01-10 |
| EP2507218A1 (fr) | 2012-10-10 |
| SG181467A1 (en) | 2012-07-30 |
| AU2010326423A1 (en) | 2012-06-21 |
| KR20120104988A (ko) | 2012-09-24 |
| CA2782701A1 (fr) | 2011-06-09 |
| BR112012012908A2 (pt) | 2015-09-08 |
| UY33080A (es) | 2011-06-01 |
| TW201127790A (en) | 2011-08-16 |
| JP2013512883A (ja) | 2013-04-18 |
| CN102906076A (zh) | 2013-01-30 |
| WO2011067538A1 (fr) | 2011-06-09 |
| MX2012006388A (es) | 2012-06-19 |
| FR2953518A1 (fr) | 2011-06-10 |
| US20120302759A1 (en) | 2012-11-29 |
| FR2953518B1 (fr) | 2012-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR091279A1 (es) | Inhibidores macrociclicos de virus flaviviridae | |
| UY28878A1 (es) | Compuestos de aril-o heteroarilamida ortosustituidos y composiciones | |
| PE20121695A1 (es) | 5-alquinil-pirimidinas | |
| HN2011003014A (es) | Neocleosidos uracilo espiro ocetano en fecha 16 de noviembre de 2011 se solicita por parte del titular de la invencion modificacion del titulo, ahora se denomina: espironucleosidos uraciclicos oxetanicos | |
| PE20091099A1 (es) | Derivados de aminobenzamida como agentes utiles para controlar parasitos animales | |
| AR082968A1 (es) | Inhibidores biciclicos de notum pectinacetilesterasa y una composicion farmaceutica en base al compuesto | |
| AR079055A1 (es) | Procedimiento para la preparacion de dabigatran etexilato e intermediarios del mismo | |
| DK1888614T3 (da) | Fremgangsmåde til fremstilling af 3alpha(beta)-7alpha(beta)-dihydroxy-6alpha(beta)-alkyl-5beta-cholansyre | |
| DOP2010000396A (es) | Derivado de uracilo o timina para el tratamiento de hepatitis c | |
| CO6220974A2 (es) | Derivados de indol 2-carboxamidas y de azaindol 2- carboxamidas sustituidos con un grupo silanilo su preparacion y su aplicacion en terapeutica | |
| AR082937A1 (es) | Fosforamidatos de nucleosido | |
| AR082004A1 (es) | Compuestos de fusion de piridina | |
| RU2009131835A (ru) | Способ получения бетамиметиков | |
| AR081893A1 (es) | Derivados de acido 1-(2-fluorobifenil-4-il)-alquil carboxilico para la terapia de la amiloidosis transtiretina | |
| AR079300A1 (es) | Procedimiento de preparacion de un derivado de combretastatina e intermediarios de reaccion | |
| PE20141201A1 (es) | Compuestos de benzofurano para el tratamiento de infecciones por el virus de hepatitis c (hcv) | |
| PE20131128A1 (es) | Metodo de produccion de un compuestos intermediario para sintetizar un medicamento | |
| JP2016516744A5 (es) | ||
| AR071744A1 (es) | Proceso para la preparacion de 6-sustituido-1-(2h)-isoquinolinonas, intermediarios para su sintesis y metodos de obtencion de estos intermediarios. | |
| AR060962A1 (es) | Proceso de preparacion de derivados de quinazolina e intermediarios de sintesis | |
| AR059613A1 (es) | Proceso para la preparacion de compuestos de dibenzotiazepina | |
| AR081720A1 (es) | Composicion para el control de plagas | |
| AR072776A1 (es) | Procesos para la produccion de 2-amino-2-[2-(4-alquil c2-20-fenil)etil]propano-1,3-dioles y a compuestos intermediarios para usar con los mismos | |
| AR049668A1 (es) | Proceso quimico para preparar esteres de 4,4 - difluorometil - 3 - oxo - butanoico por reaccion entre una amida y un ester. | |
| CO6220857A2 (es) | Derivados de azabicicloalcano su preparacion y su aplicacion terapeutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |